Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 14, 2026

Prediction of HIV-1 Coreceptor Usage (Tropism) by Sequence Analysis using a Genotypic Approach
07:06

Prediction of HIV-1 Coreceptor Usage (Tropism) by Sequence Analysis using a Genotypic Approach

Published on: December 1, 2011

Predicting human immunodeficiency virus inhibitors using multi-dimensional Bayesian network classifiers.

Hanen Borchani1, Concha Bielza, Carlos Toro

  • 1Computational Intelligence Group, Departamento de Inteligencia Artificial, Facultad de Informática, Universidad Politécnica de Madrid, Boadilla del Monte 28660, Spain. hanen.borchani@upm.es

Artificial Intelligence in Medicine
|February 5, 2013
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multimodal oral cancer detection with embedding-level oversampling of fused image and clinical data.

Scientific reports·2026
Same author

Discovering Genetic Variants in Hypertrophic Cardiomyopathy With Multiple Machine Learning Techniques.

IEEE transactions on computational biology and bioinformatics·2025
Same author

Development and Application of an Optoelectronic Sensor for Flame Monitoring of a Copper Concentrate Flash Burner.

Sensors (Basel, Switzerland)·2025
Same author

Human Mycobacterium bovis infection: A multicentre retrospective study conducted by the Madrid Study Group for Mycobacteria (GEMIMAD).

Enfermedades infecciosas y microbiologia clinica (English ed.)·2025
Same author

Infection model of THP-1 cells, growth dynamics, and antimicrobial susceptibility of clinical Mycobacterium abscessus isolates from cystic fibrosis patients: Results from a multicentre study.

PloS one·2025
Same author

BN-BacArena: Bayesian network extension of BacArena for the dynamic simulation of microbial communities.

Bioinformatics (Oxford, England)·2024
Same journal

Real-time EEG-based epileptic seizure prediction using artificial intelligence: A systematic review.

Artificial intelligence in medicine·2026
Same journal

R-peak detection and ECG data compression scheme based on empirical mode decomposition and wavelet transform.

Artificial intelligence in medicine·2026
Same journal

CastNet: A three-channel EEG-based deep learning model for cross-subject depression detection.

Artificial intelligence in medicine·2026
Same journal

State-of-the-art TinyML approaches for colorectal cancer detection: Current advances, challenges, and future directions.

Artificial intelligence in medicine·2026
Same journal

JRadiEvo: A Japanese radiology report generation model enhanced by evolutionary optimization of model merging.

Artificial intelligence in medicine·2026
Same journal

Causally-informed deep learning towards explainable and generalizable outcome prediction in critical care.

Artificial intelligence in medicine·2026
See all related articles

This study introduces MB-MBC, a new algorithm for predicting human immunodeficiency virus type 1 (HIV-1) drug resistance. It accurately identifies reverse transcriptase and protease inhibitors based on patient mutations, aiding treatment decisions.

Area of Science:

  • Computational biology
  • Machine learning
  • Virology

Background:

  • Predicting antiretroviral drug efficacy in HIV-1 patients is crucial for effective treatment.
  • Resistance mutations significantly impact the effectiveness of reverse transcriptase and protease inhibitors.
  • Existing classification methods may not fully capture the complexity of multi-dimensional drug resistance prediction.

Purpose of the Study:

  • To develop and evaluate a novel multi-dimensional Bayesian network classifier (MB-MBC) for predicting HIV-1 reverse transcriptase and protease inhibitors.
  • To assess the performance of MB-MBC against existing algorithms using real-world patient data.
  • To explore interactions between drug resistance mutations and inhibitor efficacy.

Main Methods:

  • Implementation of the MB-MBC algorithm, which learns Markov blankets around class variables using the HITON algorithm.

More Related Videos

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Related Experiment Videos

Last Updated: May 14, 2026

Prediction of HIV-1 Coreceptor Usage (Tropism) by Sequence Analysis using a Genotypic Approach
07:06

Prediction of HIV-1 Coreceptor Usage (Tropism) by Sequence Analysis using a Genotypic Approach

Published on: December 1, 2011

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

  • Application of MB-MBC to reverse transcriptase and protease inhibitor datasets from the Stanford HIV-1 database.
  • Comparative analysis of MB-MBC's classification accuracy against state-of-the-art multi-dimensional Bayesian network classifiers.

    • Main Results:

    • MB-MBC achieved promising classification accuracy for predicting both reverse transcriptase (71% mean, 11% global) and protease inhibitors (>84% mean, >31% global).
    • The graphical structures generated by MB-MBC provided insights into known and novel interactions between mutations and inhibitors.
    • The algorithm demonstrated superior or competitive performance compared to existing MBC learning algorithms.

    Conclusions:

    • The MB-MBC algorithm is an effective tool for predicting HIV-1 drug resistance.
    • MB-MBC facilitates the discovery of complex interactions within and between HIV-1 reverse transcriptase and protease inhibitor classes.
    • This approach holds potential for optimizing personalized antiretroviral therapy strategies.